SCHEMBL527094

SCHEMBL527094

O=C(O)Nc1cccc(OC(F)(F)CF)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
HTT P42858 2/20 0.46
POLB P06746 2/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
LMNA P02545 1/20 0.46
P2RX1 P51575 1/20 0.45
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11687255 0.85 EPHX2 (0.46) ALDH1A1HTTPOLBGAAMAPT
SCHEMBL2095975 0.84 ALDH1A1 (0.60) ALDH1A1HTTPOLBGAAMAPT
SCHEMBL11683088 0.83 TP53 (0.57) POLBLMNAHDAC6NPC1RAB9A
SCHEMBL2095525 0.82 PDK1 (0.49) ALDH1A1HTTPOLBGAAMAPT
SCHEMBL11004880 0.81 MAPT (0.53) ALDH1A1HTTGAAMAPTLMNA
SCHEMBL11686582 0.80 MEN1 (0.44) ALDH1A1POLBHPGDLMNANPC1
SCHEMBL2094834 0.78 LMNA (0.50) ALDH1A1HTTPOLBMAPTHPGD
SCHEMBL8350768 0.78 APP (0.44) ALDH1A1HTTPOLBGAAMAPT
SCHEMBL527095 0.78 MEN1 (0.63) HTTGAAMAPTLMNAHDAC4
SCHEMBL26135778 0.76 GRM4 (0.61) ALDH1A1HTTPOLBMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598481-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS Bristol-Myers Squibb Company (US) 2013-06-05 EP disclosed
WO-2012015723-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-02 WO disclosed